• Home
  •  / Acousia Therapeutics

Acousia Therapeutics

OverviewSuggest Edit

Acousia Therapeutics is a biotech company working to identify small molecules for treatment of hearing loss. The Company develops a technology which will help to replace lost hair cells by cellular regeneration originating from supporting cells. It works on drugs for local application, which will restore hearing in patients who have lost their hearing ability due to various reasons, e.g. noise trauma, treatment with ototoxic drugs or sudden deafness. In addition, this therapy will have the potential to treat the age-related decrease in hearing capacity.

TypePrivate
Founded2017
HQTübingen, DEMap
Websiteacousia.com
View Jobs

Locations

Acousia Therapeutics is headquartered in
Tübingen, Germany

Location Map
All Locations (1)

Latest Updates

Cybersecurity ratingAMore

Key People/Management at Acousia Therapeutics

Michael Bos

Michael Bos

CSO
Tim Boelke

Tim Boelke

CEO and Chief Medical Officer
Show more

Acousia Therapeutics Office Locations

Acousia Therapeutics has an office in Tübingen
Tübingen, DE (HQ)
Sindelfinger Straße 3
Show all (1)

Acousia Therapeutics Financials and Metrics

Summary Metrics

Founding Date

2017

Acousia Therapeutics total Funding

$14.6 m

Acousia Therapeutics latest funding size

$11.98 m

Time since last funding

3 years ago

Acousia Therapeutics investors

KfW Bankengruppe, LBBW Venture Capital GmbH, Boehringer Ingelheim Venture Fund, Bregua Corporation, Kreditanstalt für Wiederaufbau, Creathor Ventures, Axxam
Acousia Therapeutics's latest funding round in May 2018 was reported to be $12 m. In total, Acousia Therapeutics has raised $14.6 m
Show all financial metrics

Acousia Therapeutics Cybersecurity Score

Cybersecurity ratingPremium dataset

A

93/100

Learn more about our premium products
SecurityScorecard logo

Acousia Therapeutics Online and Social Media Presence

Acousia Therapeutics's Trends

Embed Graph

 Acousia Therapeutics Frequently Asked Questions

  • When was Acousia Therapeutics founded?

    Acousia Therapeutics was founded in 2017.

  • Who are Acousia Therapeutics key executives?

    Acousia Therapeutics's key executives are Michael Bos and Tim Boelke.

  • Who are Acousia Therapeutics competitors?

    Competitors of Acousia Therapeutics include Nordic Nanovector, Brii Biosciences and Prevail Therapeutics.

  • Where is Acousia Therapeutics headquarters?

    Acousia Therapeutics headquarters is located at Sindelfinger Straße 3 , Tübingen.

  • Where are Acousia Therapeutics offices?

    Acousia Therapeutics has an office in Tübingen.

  • How many offices does Acousia Therapeutics have?

    Acousia Therapeutics has 1 office.